Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
22,485,985
-
Share change
-
+1,562,547
-
Total reported value
-
$160,772,424
-
Price per share
-
$7.15
-
Number of holders
-
36
-
Value change
-
+$11,351,323
-
Number of buys
-
26
-
Number of sells
-
8
Institutional Holders of STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) as of Q2 2017
As of 30 Jun 2017,
STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,485,985 shares.
The largest 10 holders included
CAXTON CORP, NEA Management Company, LLC, Vivo Capital, LLC, Broadfin Capital, LLC, ARMISTICE CAPITAL, LLC, Opaleye Management Inc., Boxer Capital, LLC, Tredje AP-fonden, BlackRock Inc., and Granite Point Capital Management, L.P..
This page lists
36
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.